IAS News and Literature Updates:
September/October 2018

From the President's Desk:

Yuji Matsuzawa

I am pleased to  announce that the International Atherosclerosis Society (IAS) and the FH Foundation, a patient-centered nonprofit organization dedicated to research, advocacy, and education of familial hypercholesterolemia (FH), have joined in partnership to improve awareness of FH and elevate FH on the global policy stage. FH is the most common genetic condition leading to very high cholesterol and early heart disease. One in 220 people or 30 million worldwide have FH, but 90% are undiagnosed. Press Release <

LET'S KEEP IN TOUCH
              
I am pleased to announce that the IAS is now on social media.
                    Facebook: https://www.facebook.com/atherosociety/
                    Twitter: https://twitter.com/atherosociety
                    LinkedIn: https://www.linkedin.com/groups/8689597/

     


    FH Activities: News from the World    

Also included in this Newsletter:
In the News: 
 
     Featured Commentaries    

Scavenger Receptor CD36 Decreases Gallbladder Contractility and Promotes Gallstone Formation

By: V. Cifarelli, Y. Xie, N. Abumrad, & N.O. Davidson


Cholesterol gallstone disease (CGD) is one of the most prevalent digestive disease in both industrialized and developing western societies, affecting ≤ 15% of the adult American population. Among the pathogenic features of CGD are increased biliary cholesterol secretion, increased bile acid hydrophobicity, cholesterol microcrystal formation leading to nucleation growth and aggregation of cholesterol "sludge" with eventual formation of macroscopic stones which in turn promote gallbladder inflammation.

> View Complete Commentary <

Understanding the role of bile acid signaling in bile acid and cholesterol metabolism and metabolic diseases

By: J.Y. L. Chiang

Cholesterol homeostasis is maintained by dietary uptake and de novo synthesis, while its output by catabolism of cholesterol to bile acids, biliary excretion and biosynthesis of membranes and steroid hormones. Bile acid synthesis from cholesterol is the predominant pathway for catabolism of cholesterol, which accounts for about 50% of daily cholesterol output. Bile acid synthesis involves 15 enzymes located in microsomes, mitochondria and peroxisome.


> View Complete Commentary <

   XIX International Symposium on Atherosclerosis 2021  
 

         XX International Symposium on Atherosclerosis 2024 - Winner        
 
We are pleased to announce that after the presentation of the outstanding bids for the ISA2024 Symposium from the Russian National Atherosclerosis Society (RNAS), Emirates Cardiac Society (ECS), Lipid Association of India (LAI), and Oman Society of Lipids & Atherosclerosis (OSLA) the IAS Executive Board during its meeting held in Toronto on June 9 has selected the winner of the ISA2024: the Oman Society of Lipids and Atherosclerosis (OSLA).

 
 Upcoming Meetings 
October 11-14, 2018
 
CSA IAS Joint Session during the GWICC2018/Great Wall International Congress of Cardiology
Beijing, China
 
October 26, 2018
 
IAS Chile Symposium during the Chilean Congress on Internal Medicine
Santiago, Chile

 
 
November 30 - December 1, 2018

5th Congress on Atherosclerosis
Cites de sciences, Tunis




View Meeting Announcement
Acknowledgements
The IAS wishes to thank all the supporters which have generously offered grants to the IAS for the development of its many activities and in support of its mission: Aegerion Pharmaceuticals, Amgen, Inc., Amgen (Europe) GmbH, Amryt, Daiichi Sankyo Co., Ltd., Fondazione Giovanni Lorenzini, Ono Pharmaceutical Co., Ltd., OSLA - Oman Society of Lipids and Atherosclerosis, Otsuka Pharmaceutical Co., Ltd., Pfizer, Sanofi and Regeneron, and Weill Cornell Medical College.
>> Back To Top <<
 
IAS Newsletter Editors
&
Website Editorial Board
 
Editor-in-Chief
Scott M. Grundy, MD, PhD
Dallas, TX, USA

Associate Editors
Stefano Bellosta, PhD
Milan, Italy

Emanuela Folco, PhD
Milan, Italy

Website & Newsletter Editors
Elena Colombo
Milan, Italy
Yelonda Williams, BA
Dallas, TX, USA


Offices:
 Executive Director

Emanuela Folco, Ph.D.
International Atherosclerosis Society
Viale Piave 35 
20129 Milan, Italy 
Tel: +39 02 29006267
Fax: +39 02 29007018
E-mail: emanuela.folco@athero.org; info@athero.org
 

US Office:
International Atherosclerosis Society 
C/O MCI - Kathy Bradley
  7918 Jones Branch Drive, Suite 300
McLean, VA 22102, USA
E-mail: info@athero.org
************************************************************************************************************************************************************

You are a valued member of the International Atherosclerosis Society. You are receiving this email because you opted in at our website - www.athero.org

Unsubscribe <<Email Address>> from this list.

Our mailing address is:
International Atherosclerosis Society
Fondazione Giovanni Lorenzini Medical Science Foundation
viale Piave 35
Milan, Italy 20129
Italy

Add us to your address book

Copyright (C) 2018 International Atherosclerosis Society All rights reserved.

Forward this email to a friend
Update your profile